Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

601 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Active, not recruiting

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

NCT02650401

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States
View all 26 locations
View Trial Details
Active, not recruiting

Avelumab Program Rollover Study

NCT03815643

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +32 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California Davis Health System - Comprehensive Cancer Center Sacramento, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 104 locations
View Trial Details
Active, not recruiting

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

NCT05262400

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Administrative Address: UCLA Hematology/Oncology Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • UCLA Hematology / Oncology-Parkside Santa Monica, California, United States
View all 44 locations
View Trial Details
Active, not recruiting

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
Locations
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
  • LLC Arensia Explorer Medicine Tbilisi, Georgia
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View all 25 locations
View Trial Details

Related conditions